184 related articles for article (PubMed ID: 23856214)
1. Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation.
Tible M; Loupy A; Vernerey D; Suberbielle C; Beuscart T; Cazes A; Guillemain R; Amrein C; Pezzella V; Fabiani JN; Nochy D; Hill G; Empana JP; Jouven X; Charron D; Bruneval P; Duong Van Huyen JP
J Heart Lung Transplant; 2013 Aug; 32(8):769-76. PubMed ID: 23856214
[TBL] [Abstract][Full Text] [Related]
2. Reclassification of C4d-Positive Endomyocardial Biopsy (EMB) According to New International Society for Heart and Lung Transplantation (ISHLT) 2013 Categories for Reporting Pathologic Antibody-Mediated Rejection (pAMR): Preliminary Data from a Polish Single-Center Study.
Szymańska S; Grajkowska W; Sobieszczańska-Małek M; Zieliński T; Pronicki M
Ann Transplant; 2015 Jun; 20():351-6. PubMed ID: 26101425
[TBL] [Abstract][Full Text] [Related]
3. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
Frank R; Dean SA; Molina MR; Kamoun M; Lal P
Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent specificity of immunopathologic (C4d-CD68) and histologic criteria of antibody-mediated rejection for donor-specific antibodies and allograft dysfunction in heart transplantation.
Yerly P; Rotman S; Nobile A; Aubert V; Tozzi P; Yarol N; Vogt P; Hullin R; Pascual M
Transplantation; 2015 Mar; 99(3):586-93. PubMed ID: 24983305
[TBL] [Abstract][Full Text] [Related]
5. Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant.
Everitt MD; Hammond ME; Snow GL; Stehlik J; Revelo MP; Miller DV; Kaza AK; Budge D; Alharethi R; Molina KM; Kfoury AG
J Heart Lung Transplant; 2012 Jul; 31(7):686-93. PubMed ID: 22551931
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory cell burden and phenotype in endomyocardial biopsies with antibody-mediated rejection (AMR): a multicenter pilot study from the AECVP.
Fedrigo M; Leone O; Burke MM; Rice A; Toquet C; Vernerey D; Frigo AC; Guillemain R; Pattier S; Smith J; Lota A; Potena L; Bontadini A; Ceccarelli C; Poli F; Feltrin G; Gerosa G; Manzan E; Thiene G; Bruneval P; Angelini A; Duong Van Huyen JP
Am J Transplant; 2015 Feb; 15(2):526-34. PubMed ID: 25612500
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts.
Li F; Wei J; Valenzuela NM; Lai C; Zhang Q; Gjertson D; Fishbein MC; Kobashigawa JA; Deng M; Reed EF
J Heart Lung Transplant; 2015 Apr; 34(4):580-587. PubMed ID: 25511749
[TBL] [Abstract][Full Text] [Related]
8. Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.
Clerkin KJ; Farr MA; Restaino SW; Zorn E; Latif F; Vasilescu ER; Marboe CC; Colombo PC; Mancini DM
J Heart Lung Transplant; 2017 May; 36(5):540-545. PubMed ID: 27916323
[TBL] [Abstract][Full Text] [Related]
9. Correlation of circulating donor-specific anti-HLA antibodies and presence of C4d in endomyocardial biopsy with heart allograft outcomes: a single-center, retrospective study.
Frank R; Molina MR; Wald JW; Goldberg LR; Kamoun M; Lal P
J Heart Lung Transplant; 2013 Apr; 32(4):410-7. PubMed ID: 23498162
[TBL] [Abstract][Full Text] [Related]
10. Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection.
Loupy A; Duong Van Huyen JP; Hidalgo L; Reeve J; Racapé M; Aubert O; Venner JM; Falmuski K; Bories MC; Beuscart T; Guillemain R; François A; Pattier S; Toquet C; Gay A; Rouvier P; Varnous S; Leprince P; Empana JP; Lefaucheur C; Bruneval P; Jouven X; Halloran PF
Circulation; 2017 Mar; 135(10):917-935. PubMed ID: 28148598
[TBL] [Abstract][Full Text] [Related]
11. Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection.
Fedrigo M; Feltrin G; Poli F; Frigo AC; Benazzi E; Gambino A; Tona F; Caforio AL; Castellani C; Toscano G; Gerosa G; Thiene G; Angelini A
J Heart Lung Transplant; 2013 Apr; 32(4):404-9. PubMed ID: 23498161
[TBL] [Abstract][Full Text] [Related]
12. Role of morphologic parameters on endomyocardial biopsy to detect sub-clinical antibody-mediated rejection in heart transplantation.
Fedrigo M; Gambino A; Benazzi E; Poli F; Frigo AC; Tona F; Caforio AL; Castellani C; Toscano G; Feltrin G; Gerosa G; Thiene G; Angelini A
J Heart Lung Transplant; 2011 Dec; 30(12):1381-8. PubMed ID: 21930398
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of Endothelial HLA Class II is a Marker of Antibody-Mediated Rejection in Heart Allograft Biopsies.
Cai Q; Moore SA; Hendricks AR; Torrealba JR
Transplant Proc; 2020 May; 52(4):1192-1197. PubMed ID: 32197864
[TBL] [Abstract][Full Text] [Related]
14. ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis.
Hammond MEH; Revelo MP; Miller DV; Snow GL; Budge D; Stehlik J; Molina KM; Selzman CH; Drakos SG; Rami A A; Nativi-Nicolau JN; Reid BB; Kfoury AG
J Heart Lung Transplant; 2016 Mar; 35(3):320-325. PubMed ID: 26970471
[TBL] [Abstract][Full Text] [Related]
15. Early screening for antibody-mediated rejection in heart transplant recipients.
Kfoury AG; Hammond ME; Snow GL; Stehlik J; Reid BB; Long JW; Gilbert EM; Bader FM; Bull DA; Renlund DG
J Heart Lung Transplant; 2007 Dec; 26(12):1264-9. PubMed ID: 18096477
[TBL] [Abstract][Full Text] [Related]
16. Correlation Between Microvascular Inflammation in Endomyocardial Biopsies and Rejection Transcripts, Donor-specific Antibodies, and Graft Dysfunction in Antibody-mediated Rejection.
Coutance G; Zouhry I; Racapé M; Drieux F; Viailly PJ; Rouvier P; François A; Chenard MP; Toquet C; Rabant M; Berry GJ; Angelini A; Bruneval P; Duong Van Huyen JP
Transplantation; 2022 Jul; 106(7):1455-1464. PubMed ID: 34954735
[TBL] [Abstract][Full Text] [Related]
17. Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients?
Peng DM; Law YM; Kemna MS; Warner P; Nelson K; Boucek RJ
Pediatr Transplant; 2013 Aug; 17(5):429-35. PubMed ID: 23551503
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Circulating Complement-Fixing Donor-Specific Antibodies Identified by the C1q Assay and Presence of C4d in Endomyocardial Biopsy Specimens.
Frank R; Lal P; Kearns J; Molina MR; Wald JW; Goldberg LR; Kamoun M
Am J Clin Pathol; 2016 Jan; 145(1):62-8. PubMed ID: 26712872
[TBL] [Abstract][Full Text] [Related]
19. Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.
Fisher PE; Suciu-Foca N; Ho E; Michler RE; Rose EA; Mancini D
J Heart Lung Transplant; 1995; 14(6 Pt 1):1156-61. PubMed ID: 8719463
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor and antibodies to HLA and MICA antigens in heart transplant recipients.
Pavlova YA; Malek I; Honsova E; Netuka I; Sochman J; Lodererova A; Kolesar L; Striz I; Skibova J; Slavcev A
Tissue Antigens; 2010 Nov; 76(5):380-6. PubMed ID: 20604893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
